(Q61980775)
Statements
A Phase IIa, Multicenter, Randomized, Placebo- and Active-Comparator Controlled, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (English)
0 references
24 March 2009
0 references
12 July 2010
0 references
118
0 references
18 year
0 references
70 year
0 references